כל הפוסטים בעדכונים
רמות AMH מנבאות קצב אובדן עצם במהלך מעבר למנופאוזה (J Bone Miner Res.)
בנשים עם רמות AMH (Anti-Mullerian Hormone) נמוכות ייתכן אובדן עצם נרחב יותר במהלך המעבר למנופאוזה, כך עולה מתוצאות מחקר חדש שפורסמו בכתב
Retrospective evaluation of persistence in osteoporosis therapy with oral bisphosphonates in Italy: the TOBI study
Summary The patients’ persistence with osteoporosis treatments is low. This retrospective, multicenter survey showed that almost 30% of osteoporotic patients
Hip fracture, mortality risk, and cause of death over two decades
Abstract Men and women with hip fracture have higher short-term mortality. This study investigated mortality risk over two decades post-fracture;
Modulation of gastric pH by a buffered soluble effervescent formulation: A possible means of improving gastric tolerability of alendronate
Abstract Gastrointestinal side-effects of alendronate (ALN) are believed to be associated with oesophageal lodging of tablets and perhaps reflux of
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures
Abstract Context.— Alendronate sodium reduces fracture risk in postmenopausal women who have vertebral fractures, but its effects on fracture risk have